BNET Industries
- Private
- CA
Dow Jones Description
Only 30 minutes from the heart of downtown Vancouver, the University of British Columbia holds an international reputation for excellence in advanced research and learning. The spectacular UBC campus is a 'must-see' for any visitor to the city -- where snow-capped mountains meet ocean, and breathtaking vistas greet you around every corner. The university boasts some of the city's best attractions & recreation facilities, including the Museum of Anthropology, the Chan Centre for the Performing Arts, the UBC Botanical Garden and Centre for Plant Research, and endless opportunities to explore forested trails in the adjoining 763-hectare Pacific Spirit Regional Park.
Contact Information
2329 West Mall
Vancouver, British Columbia V6T 1Z4
604.822.2211
NAICS Code Colleges, Universities, and Professional Schools: 611310
News & Analysis
Filter by
protein and university of british columbia - All News and Analysis
University of British Columbia obtains United States patent.(for translocated intimin receptor)(Brief article)
University of British Columbia (Vancouver, Canada) has patented a polypeptide, called Tir (for translocated intimin receptor, which is secreted by attaching and effacing pathogens, such as the enteropathogenic and enterohemorrhagic E. coli. These bacterial pathogens inserts their own receptors into mammalian cell surfaces, to which...
Royal Society of Canada 2002 New Fellows: Making a Difference to Lives of Canadians.
OTTAWA, ONTARIO, Jun 26, 2002 The Royal Society of Canada, the Canadian Academy of the Sciences and Humanities, has elected fifty-eight new Fellows, four Specially Elected Fellows and two Foreign Fellows to its ranks. In keeping with the motto of the Society, "different paths,...
University of British Columbia obtains United States patent.(family of proteins)(Brief Article)
University of British Columbia (Vancouver, Canada) has patented a family of proteins, including a specific human protein designated as HIP1, has been identified that interact differently with the gene product of a normal (16 CAG repeat) and an expanded (>44 CAG repeat) HD gene. Expression of...
Small Molecule Drug Candidates Developed at Receptagen Ltd
EDMONDS, WASHINGTON--BUSINESS WIRE--Oct. 21, 1997--Receptagen Ltd. (TSE:RCG/OTCBB:RCEPF) disclosed the publication of articles in scientific journals describing two different drug approaches to achieving proprietary "Growth Blocker" technology. The papers were co-authored by Receptagen scientists, along with collaborators from the University of Washington, the University of British Columbia and the...
- 1
IndustryTop Rated
- Google Offers Free Downloads of a Million Books 11 votes
- InsideView Disrupts Legacy Business Info Publishers Like Hoover's 9 votes
- Mobile is the New Mass Medium, For Better or Worse 8 votes
- As Income Mobility Falls, American Dream Fades 7 votes
- Information Overload: The Small Role (8-9 percent) for News 7 votes


